HUN vs KWR: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: KWR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HUN and KWR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HUN and KWR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Huntsman Corporation is a global manufacturer of differentiated and specialty chemicals organized into three segments: Polyurethanes (MDI, polyols and TPU used in insulation, automotive seating, adhesives, coatings and footwear), Performance Products (amines, surfactants and maleic anhydride for agriculture, energy, personal care and construction), and Advanced Materials (epoxy, phenoxy, acrylic and polyurethane formulations for aerospace, electronics and industrial uses). It is roughly the fourth-largest MDI producer worldwide, behind Wanhua Chemical, BASF and Covestro.

Full HUN guide

Quaker Houghton, formed by the 2019 merger of Quaker Chemical and Houghton International, supplies process fluids and chemical management services used in making and shaping metal. Its products (metalworking fluids, hydraulic fluids, corrosion protection, cleaners, and surface treatments) are consumed on customer production lines in automotive, steel, aluminum, aerospace, and general industrial markets, and the company leans on formulation expertise, on-site technical service, and a razor-and-blade recurring-revenue model rather than commodity pricing. It generated roughly $1.85 billion in trailing revenue and carried a market capitalization of about $2.6 billion as of July 2026.

Full KWR guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• HUN drivers: Pending Olin merger; Polyurethanes and MDI cycle.
• KWR drivers: Industrial demand recovery and volume growth; Margin expansion and the transformation program.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. For KWR, kWR is cyclical, so a slowdown in automotive, steel, or broader industrial production would pressure both volumes and pricing.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick HUN if you believe its drivers more; KWR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HUN and KWR guides.

HUN. Huntsman is currently unprofitable on a trailing basis, so a positive P/E is not meaningful and investors lean on revenue, EBITDA and leverage. As of mid-2026 the stock traded around $10 to $11 with a 52-week range of roughly $7.30 to $16, and the dividend yield screened high partly because the price had fallen. With a merger agreed, valuation is best read against the Olin exchange ratio rather than standalone multiples.

KWR. Reported GAAP earnings have at times been distorted by non-cash impairment and intangible charges, which pushed the headline P/E to extreme levels, so investors typically watch non-GAAP EPS and adjusted EBITDA instead. On an adjusted basis the stock trades in the low-20s earnings multiple, roughly in line with other mid-cap specialty-chemicals names. The steadily rising dividend and recurring service revenue are central to the valuation case.

Headline figures (approximate, JULY 2026): HUN shows revenue (fy2025) ~$5.7B, revenue (q1 2026) ~$1.42B, net loss (fy2025) ~$275M, diluted eps (fy2025) ~-$1.59; KWR shows revenue (ttm) ~$1.85B, market cap ~$2.6B, adjusted ebitda (ttm) ~$290M, non-gaap eps (ttm) ~$6.5.

HUN and KWR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HUN and KWR exposure against your real portfolio. It is not an investment adviser.